Schering-Plough is a global science-based company that discovers, develops and manufactures pharmaceuticals for three customer markets -- human prescription, consumer and animal health. While most of the research and development activity is directed toward prescription products, there are important applications of this central research and development platform into the consumer healthcare and animal health products. Schering-Plough also accesses external innovation via partnering, in-licensing and acquisition for all three customer markets. Schering-Plough is based in Kenilworth, N.J.
DISCLOSURE NOTICE: The information in this press release and other
written reports and oral statements made from time to time by
Schering-Plough may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements do not relate strictly to historical or current facts and are
based on current expectations or forecasts of future events. You can
identify these forward- looking statements by their use of words such as
"anticipate," "believe," "could," "estimate," "expect," "forecast,"
"project," "intend," "plan," "potential," "will," and other similar words
and terms. Actual results may vary materially from Schering-Plough's
forward-looking statements, and there are no guarantees about the
performance of Schering-Plough stock or Schering- Plough's business.
Schering-Plough does not assume the obligation to update any
forward-looking statement. A number of risks and uncertainties could cause
results to differ materially from forward-looking statements. For further
details of these risks and uncertainties that may impact forward- looki
|SOURCE Schering-Plough Corporation|
Copyright©2007 PR Newswire.
All rights reserved